Your browser doesn't support javascript.
loading
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancer.
Watanabe, Satomi; Yonesaka, Kimio; Tanizaki, Junko; Nonagase, Yoshikane; Takegawa, Naoki; Haratani, Koji; Kawakami, Hisato; Hayashi, Hidetoshi; Takeda, Masayuki; Tsurutani, Junji; Nakagawa, Kazuhiko.
Afiliación
  • Watanabe S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Yonesaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Tanizaki J; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nonagase Y; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Takegawa N; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Haratani K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Takeda M; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Tsurutani J; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nakagawa K; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
Cancer Med ; 8(3): 1258-1268, 2019 03.
Article en En | MEDLINE | ID: mdl-30701699
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Transducción de Señal / Receptor ErbB-2 / Resistencia a Antineoplásicos / Receptor ErbB-3 / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Med Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Transducción de Señal / Receptor ErbB-2 / Resistencia a Antineoplásicos / Receptor ErbB-3 / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Med Año: 2019 Tipo del documento: Article País de afiliación: Japón